21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
32.50.Z - Production of medical devices, instruments, and products, including dental products
46.46.Z - Wholesale trade of pharmaceutical and medical products
47.91.Z - Intermediary retail sale, non-specialized
63.12.Z - Services related to computing infrastructure, data processing, website management (hosting), and other information services
70.22.Z - Head office activities and management consultancy
72.11.Z - Scientific research and development activities
73.11.Z - Advertising agency activities
78.10.Z - Employment placement and recruitment services
82.30.Z - Activities related to organizing fairs, exhibitions, and congresses
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 0,3 | 1 | 1,4 | 41,1 |
EBITDA | 0,3 | 1 | 1,4 | 38,5 |
Short time liabilities | 0,5 | 0,4 | 0,2 | -54,7 |
Equity capital | 0,3 | 1,2 | 2,4 | 105,1 |
Operating profit (EBIT) | 0,3 | 1 | 1,4 | 42,1 |
Assets | 0,8 | 1,5 | 2,6 | 66,4 |
Net profit (loss) | 0,3 | 0,9 | 1,2 | 41,5 |
Cash | 0,1 | 0,1 | 0,3 | 151,7 |
Liabilities and provisions for liabilities | 0,5 | 0,4 | 0,2 | -54,1 |
Net income from sale | 1,1 | 2,8 | 4 | 45,5 |
Working assets | 0,8 | 1,5 | 2,6 | 66,4 |
Depreciation | 0 | 0 | 0 | -100 |
% | % | % | p.p. | |
Profitability of capital | 98,3 | 74,3 | 51,3 | -23 |
Equity capital to total assets | 36,8 | 75,7 | 93,3 | 17,6 |
Gross profit margin | 30,2 | 34,6 | 33,5 | -1,1 |
EBITDA Margin | 31,2 | 35,6 | 33,9 | -1,7 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 174 | 47 | 15 | -32 |
Current financial liquidity indicator | 1.5448120832443237 | 4.110455513000488 | 14.899131774902344 | 10,8 |
Net dept to EBITDA | 0.6835139393806458 | 0.17555536329746246 | -0.14858251810073853 | -0,3 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane